These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 14744222)

  • 1. Clinical implications of reinforcement as a determinant of substance use disorders.
    Higgins ST; Heil SH; Lussier JP
    Annu Rev Psychol; 2004; 55():431-61. PubMed ID: 14744222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the pharmacological and nonpharmacological factors that modulate drug reinforcement.
    Sigmon SC
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):1-20. PubMed ID: 17295581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of voucher-based reinforcement therapy for substance use disorders.
    Lussier JP; Heil SH; Mongeon JA; Badger GJ; Higgins ST
    Addiction; 2006 Feb; 101(2):192-203. PubMed ID: 16445548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reinforcing functions of drugs and assessment of abuse liability.
    Brady J
    NIDA Res Monogr; 1988; 81():440-56. PubMed ID: 3136383
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of impulsivity in the development of substance use and eating disorders.
    Dawe S; Loxton NJ
    Neurosci Biobehav Rev; 2004 May; 28(3):343-51. PubMed ID: 15225976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential sources of reinforcement and punishment in a drug-free treatment clinic: client and staff perceptions.
    Roll JM; Chudzynski JE; Richardson G
    Am J Drug Alcohol Abuse; 2005; 31(1):21-33. PubMed ID: 15768569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contingency management for treatment of substance abuse.
    Stitzer M; Petry N
    Annu Rev Clin Psychol; 2006; 2():411-34. PubMed ID: 17716077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug dependence studies in laboratory animals.
    Yanagita T
    NIDA Res Monogr; 1978; (19):179-90. PubMed ID: 106285
    [No Abstract]   [Full Text] [Related]  

  • 10. Promising new biological and behavioral correlates of the reinforcing properties of drugs.
    Mendelson JH; Mello NK; Lukas SE; Woods BT; Teoh SK
    NIDA Res Monogr; 1989; 92():307-40. PubMed ID: 2512499
    [No Abstract]   [Full Text] [Related]  

  • 11. The Substance Use Risk Profile Scale: a scale measuring traits linked to reinforcement-specific substance use profiles.
    Woicik PA; Stewart SH; Pihl RO; Conrod PJ
    Addict Behav; 2009 Dec; 34(12):1042-55. PubMed ID: 19683400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulsivity as a common process across borderline personality and substance use disorders.
    Bornovalova MA; Lejuez CW; Daughters SB; Zachary Rosenthal M; Lynch TR
    Clin Psychol Rev; 2005 Sep; 25(6):790-812. PubMed ID: 16005556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between reinforcing properties and sensory/motor toxicity of CNS depressants; implications for the assessment of abuse liability.
    Brady JV; Lukas SE; Hienz RD
    NIDA Res Monogr; 1983 Apr; 43():196-202. PubMed ID: 6410252
    [No Abstract]   [Full Text] [Related]  

  • 14. Common mechanisms of reinforcement from alcohol and other drugs.
    George FR; Ritz MC
    Alcohol Alcohol Suppl; 1991; 1():427-31. PubMed ID: 1845572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy for patients with substance abuse from point of view of brain science and spirituality].
    Kuniwaki H
    Seishin Shinkeigaku Zasshi; 2001; 103(12):1055-60. PubMed ID: 11925844
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessons learned from a randomized trial of fixed and escalating contingency management schedules in opioid-dependent pregnant women.
    Tuten M; Svikis DS; Keyser-Marcus L; O'Grady KE; Jones HE
    Am J Drug Alcohol Abuse; 2012 Jul; 38(4):286-92. PubMed ID: 22352784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring substance-free and substance-related reinforcement in the natural environment.
    Correia CJ; Carey KB; Borsari B
    Psychol Addict Behav; 2002 Mar; 16(1):28-34. PubMed ID: 11934083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceived effects of substance use: a general theory.
    Smith GM
    NIDA Res Monogr; 1980 Mar; 30():50-8. PubMed ID: 6779196
    [No Abstract]   [Full Text] [Related]  

  • 19. Cash value of voucher reinforcers in pregnant drug-dependent women.
    Rosado J; Sigmon SC; Jones HE; Stitzer ML
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):41-7. PubMed ID: 15727502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.